Carisoprodol Tablet
Product Images NDC 76420-852

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 76420-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (250 mg (100 Tablet Bottle))

Package Label-principal Display Panel (250 mg (100 Tablet Bottle))
Labels for Carisoprodol Tablets USP 250 mg by Enovachem Pharmaceuticals, distributed by Rising Pharma Holdings, Inc. The labels indicate packaging quantities of 30, 60, 90, and 100 tablets. Each label includes NDC numbers, QR codes, control information, and caution statements about prescription dispensing and storage instructions.*
FDA Label Image

Package Label-principal Display Panel (350 mg (100 Tablet Bottle))

Package Label-principal Display Panel (350 mg (100 Tablet Bottle))
Carisoprodol Tablets USP 350 mg oral tablet labels from Enovachem Pharmaceuticals, showing various package quantities (30, 60, 90 tablets) and relabeled packages by the same manufacturer with quantities of 100, 500, and 1000 tablets. Labels include NDC numbers (76420-853-xx), package descriptions, barcodes, and regulatory warnings. Distributed by Rising Pharma Holdings, Inc.*
FDA Label Image

Str1 (Carisoprodol Str)

Str1 (Carisoprodol Str)
Chemical structure of carisoprodol depicting its molecular framework with labeled functional groups including carbamate and amide moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.